Braeburn
Joshua Cohen, MD, is the Chief Medical Officer at Braeburn. Joshua was previously the Global TA Lead Migraine and Headache at Teva Pharmaceuticals from March 2016 to September 2021. Prior to that, they were the Director of Education for the Department of Neurology at Mount Sinai Beth Israel, Mount Sinai St. Luke's, and Mount Sinai Roosevelt from July 2014 to December 2015. Joshua also served as the Director, Headache Fellowship Program at Mount Sinai St. Luke's and Mount Sinai West from July 2008 to December 2015.
Joshua Cohen attended Harvard University for their undergraduate degree in biology, then went on to earn their MD at New York Medicine Jobs. Joshua then completed their MPH in health policy at Columbia | SIPA.
They work with Paul Johnson - Chief Commercial Officer, Christina Malin - Executive Director & Head, Manufacturing, and Louis Ricigliano - CFO. Their manager is Mike Derkacz, President & CEO.
This person is not in any offices
Braeburn
Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder. They are committed to advancing next-generation therapies, with individualized dosing regimens and delivery options, to address the escalating disease burden of opioid use disorder faced by patients, healthcare professionals, payers and society.